401 filings
Page 6 of 21
SC TO-I
xxvc vdxqowglzln5
29 Mar 07
Issuer tender offer statement
12:00am
425
6e779oih u8ip
29 Mar 07
Business combination disclosure
12:00am
S-1/A
idgzedm vtpygcll
29 Mar 07
IPO registration (amended)
12:00am
S-1
fy0a jr3zc14luucs4j
15 Mar 07
IPO registration
12:00am
8-K
pptcnkji02w05ls
5 Mar 07
Abbott Canada Launches Oscient Pharmaceuticals’ FACTIVE Tablets in Canada
12:00am
8-K
636kifc3 95
28 Feb 07
Oscient Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2006
12:00am
8-K
zonow6y36w2r3g
23 Feb 07
New Treatment Guidelines for Community-Acquired Pneumonia Highlight Utility of FACTIVE Tablets
12:00am
8-K
9zc24xuecijz5u
9 Jan 07
Oscient Pharmaceuticals Provides Preliminary Revenue Results for Fourth Quarter and Fiscal Year 2006
12:00am
8-K
oppm2k3j8ej14urz0xtl
4 Jan 07
Entry into a Material Definitive Agreement
12:00am
8-K
d0j88xba
29 Dec 06
Oscient Pharmaceuticals Amends FACTIVE License Agreement with LG Life Sciences
12:00am
8-K
360riv
11 Dec 06
Departure of Directors or Principal Officers
12:00am
8-K
82gh2n55q2j
8 Dec 06
Other Events
12:00am
8-K
qfal2c89breg0
28 Nov 06
FDA Accepts as “Complete Response” Oscient Pharmaceuticals’ Submission Following
12:00am
8-K
e1j6wak8g qkl
22 Nov 06
Departure of Directors or Principal Officers
12:00am
8-K
a0wcy0eye66re2t quhj
15 Nov 06
Material Modifications to Rights of Security Holders
12:00am
8-K
qkm p9b7jw04yh
14 Nov 06
Regulation FD Disclosure
12:00am
8-K
j8if0c
9 Nov 06
Oscient Pharmaceuticals Reports Financial Results for Third Quarter of 2006
12:00am